Branched synthetic peptide conjugate
AssigneeThe Ontario Cancer Institute
InventorJean Gariepy
Life of this patent
Estimating the term…
Abstract
The invention is a branched synthetic peptide conjugate which can be designed to bind to a target cell surface receptor, to penetrate into target cells, and to deliver a diagnostic probe or cytotoxic functionality to a desired site of action. The invention provides a relatively small molecule of flexible design having a branched structure for systematically incorporating a desired number of cytotoxic functions, peptide-based localization signals or diagnostic probes. The invention addresses problems associated with protein-based therapeutic or diagnostic agents.
Claims7
A branched synthetic peptide conjugate intracellular vehicle having the formula I:
- ##STR7## where D is a domain which is a peptide or peptide mimic specific for binding to a target cell surface receptor, or for enabling the transport of the branched synthetic peptide conjugate across the plasma membrane of a cell, or for localization into a specific internal cell compartment;
- a cytotoxic group;
- or a diagnostic probe;
- J is linear and may be a junctional segment or spacer that may have a chemically active moiety or a marker, a carboxy-terminal structural unit which is an amino acid residue, or a short peptide;
- BP is a branched polymer comprising diaminocarboxylic acid residues which provide the branched synthetic peptide conjugate with a plurality of amino-terminal portions;
- where each of a, b, c, d, e, f, s, t, u, or v may be 0 or 1;
- and at least two of a, c, e, s and u is 1;
- n is an integer .gtoreq.2;
- and under physiological conditions
- one of D.sup.1, D.sup.2 or D.sup.3 is present and is a polycationic linear peptide or peptide mimic which enables the transport of the branched synthetic peptide conjugate across the plasma membrane of a cell.
Dependencies are inferred from the claim text.